KU-60019

製品コードS1570 バッチS157011

印刷

化学情報

 Chemical Structure Synonyms N/A Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C30H33N3O5S

分子量 547.67 CAS No. 925701-49-1
Solubility (25°C)* 体外 DMSO (warmed with 50ºC water bath) 100 mg/mL (182.59 mM)
Water Insoluble
Ethanol Insoluble
体内 (毎回新しく調製した物を用意してください)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

5.000mg/ml (9.13mM) Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to make it clear; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.
in vitro

Compared to KU-55933, KU-60019 is an improved inhibitor of the ATM kinase, while displaying similar target selectivity. This compound has little activity against DNA-PKcs and ATR with IC50 values of 1.7 μM and >10 μM, respectively, as well as 229 other protein kinases such as PI3K, mTOR and mTOR/FKBP12. It displays 3- to 10-fold more potency than KU-55933 at blocking radiation-induced phosphorylation of key ATM protein targets such as p53, γ-H2AX, and CHK2, in human glioma U87 and U1242 cells, as 1 μM of this inhibitor significantly induces >70% decrease of p53 (S15) phosphorylation to which extent ~10 μM of KU-55933 is required to achieve. This chemical effectively radiosensitizes human glioma cells with dose-enhancement ratio of 1.7 and 4.4 at 1 μM and 10 μM, respectively, and also radiosensitizes the normal fibroblasts but not the A-T fibroblasts. Its treatment (3 μM) blocks basal and insulin-induced AKT S473 phosphorylation by 70% and ~50%, respectively, and completely reduces radiation-induced AKT phosphorylation below the level of control. The effect of this agent on AKT S473 phosphorylation can be seen in glioma cell lines and normal fibroblasts but not in A-T (h-TERT) cells, and can be significantly blocked by phosphatase inhibitor okadaic acid, suggesting a critical role of ATM kinase in regulating AKT phosphorylation via unknown phosphatase. Consistent with the inhibition of prosurvival AKT signaling, it at 3 μM significantly inhibits migration and invasion of human glioma U87 cells by >70% and ~60%, respectively, as well as U1242 cells by >50% and ~60% respectively. [1]

in vivo

In orthotopic glioma U1242/luc-GFP xenograft models, the combination of KU-60019 and radiation significantly increases survival of mice than this compound alone, radiation alone, or no treatment. In addition, p53-mutant gliomas is much more sensitive to this chemical radiosensitization than wild-type glioma. [2]

特徴 Improved analog of KU-55933, and is more effective at blocking ATM-mediated DDR events.

プロトコル(参考用のみ)

細胞アッセイ 細胞株 U87 and U1242
濃度 Dissolved in water, final concentrations ~3 μM
反応時間 1, 3, and 5 days
実験の流れ

Cells are exposed to KU-60019 for 1, 3, and 5 days. Cell growth is determined by AlamarBlue. This compound is added to the medium to the recommended final concentration. Plates are incubated for 1 hour at 37 °C, fluorescence is determined on a Fluoro-Count plate reader (excitation 530 nm, emission 590 nm), and values are taken as a measure of cell growth. Cell survival is determined by trypan blue/fluorescence activated cell sorting (FACS) assay.

動物実験 動物モデル Athymic female mice harboring orthotopic glioma U1242/luc-GFP tumors or human glioma U1242/luc-GFP tumors
投薬量 KU-60019 (10 μM) is delivered at a rate of 0.5 μL/h by osmotic pump; KU-60019 (250 μM) in 12.5 μL is infused by CED.
投与方法 Administered intratumorally by convection-enhanced delivery or osmotic pump

参考

  • https://pubmed.ncbi.nlm.nih.gov/19808981/
  • https://pubmed.ncbi.nlm.nih.gov/23620409/

カスタマーフィードバック

Data from [Brain Pathol, 2012, 22(5), 677-88]

Data from [Data independently produced by , , Brain Pathol, 2012, 22(5): 677-88 ]

Data from [Data independently produced by , , Brain Pathol, 2012, 22(5): 677-88 ]

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

Phase separation of ERCC6L2-CtIP regulates the extent of DNA end resection [ Nat Cell Biol, 2025, 27(10):1771-1784] PubMed: 40913148
R406 and its structural analogs reduce SNCA/α-synuclein levels via autophagic degradation [ Autophagy, 2025, 1-17.] PubMed: 40143425
Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven disease [ Cell Rep, 2025, 44(4):115457] PubMed: 40163359
Loss of genome maintenance is linked to mTOR complex 1 signaling and accelerates podocyte damage [ JCI Insight, 2025, 10(12)e172370] PubMed: 40392611
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma [ Cancer Sci, 2025, 10.1111/cas.70043] PubMed: 40052411
Nuclear accumulation of YTHDF1 regulates mRNA splicing in the DNA damage response [ Sci Adv, 2025, 11(16):eado7660] PubMed: 40238889
Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage [ Res Sq, 2025, rs.3.rs-7303237] PubMed: 40831504
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma [ Nat Biomed Eng, 2024, 10.1038/s41551-024-01273-9] PubMed: 39658630
Inhibition of topoisomerase 2 catalytic activity impacts the integrity of heterochromatin and repetitive DNA and leads to interlinks between clustered repeats [ Nat Commun, 2024, 15(1):5727] PubMed: 38977669
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I [ Cell Death Dis, 2024, 15(7):519] PubMed: 39033176

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。